- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 207/09 - Radicals substituted by nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 207/09
Total number of patents in this class: 447
10-year publication summary
|
35
|
35
|
36
|
33
|
48
|
38
|
30
|
30
|
31
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 297 |
10 |
| Theravance Biopharma R&D IP, LLC | 517 |
9 |
| Concentric Analgesics, Inc. | 24 |
8 |
| Ligand Pharmaceuticals Incorporated | 119 |
8 |
| LB Pharmaceuticals Inc. | 19 |
8 |
| Merck Sharp & Dohme Corp. | 2218 |
7 |
| Massachusetts Institute of Technology | 9903 |
7 |
| Saniona A/S | 47 |
7 |
| Novartis AG | 11297 |
6 |
| Bristol-myers Squibb Company | 4886 |
6 |
| F. Hoffmann-La Roche AG | 7942 |
6 |
| Janssen Pharmaceutica N.V. | 3625 |
6 |
| H. Lundbeck A/S | 1247 |
6 |
| Hoffmann-La Roche Inc. | 3252 |
5 |
| Takeda Pharmaceutical Company Limited | 2945 |
5 |
| ObsEva S.A. | 62 |
5 |
| Oryzon Genomics S.A. | 105 |
5 |
| Tetraphase Pharmaceuticals, Inc. | 50 |
5 |
| Mission Therapeutics Limited | 79 |
5 |
| Nocion Therapeutics, Inc. | 46 |
5 |
| Other owners | 318 |